We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+9.16%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.11B
AUM Growth
+$353M
Cap. Flow
+$219M
Cap. Flow %
10.39%
Top 10 Hldgs %
27.96%
Holding
1,348
New
141
Increased
949
Reduced
206
Closed
51

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$21.7M
2
AAPL icon
Apple
AAPL
+$6.71M
3
INTC icon
Intel
INTC
+$5.15M
4
MSFT icon
Microsoft
MSFT
+$5.02M
5
META icon
Meta Platforms (Facebook)
META
+$4.51M

Sector Composition

Rank Sector Weight
1 Healthcare 38.07%
2 Technology 12.44%
3 Communication Services 8.78%
4 Consumer Discretionary 7.64%
5 Financials 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
1
Gilead Sciences
GILD
$162B
$113M 5.34%
1,112,550
-16,941
-1% -$1.76M
AMGN icon
2
Amgen
AMGN
$198B
$94.4M 4.48%
581,491
-1,912
-0.3% -$301K
CELG
3
DELISTED
Celgene Corp
CELG
$72.7M 3.45%
606,633
-1,704
-0.3% -$197K
ABBV icon
4
AbbVie
ABBV
$448B
$69.4M 3.29%
1,170,995
-22,688
-2% -$1.31M
BIIB icon
5
Biogen
BIIB
$29.2B
$52.7M 2.5%
172,109
-8,739
-5% -$2.51M
AAPL icon
6
Apple
AAPL
$4.79T
$48M 2.28%
1,823,140
+234,636
+15% +$6.71M
AMZN icon
7
Amazon
AMZN
$2.63T
$37M 1.75%
1,094,320
+109,840
+11% +$3.46M
MSFT icon
8
Microsoft
MSFT
$2.9T
$36.1M 1.71%
650,458
+95,364
+17% +$5.02M
REGN icon
9
Regeneron Pharmaceuticals
REGN
$68.3B
$33.3M 1.58%
61,385
+762
+1% +$413K
ALXN
10
DELISTED
Alexion Pharmaceuticals
ALXN
$33.2M 1.58%
174,063
+93
+0.1% +$16.2K
META icon
11
Meta Platforms (Facebook)
META
$1.59T
$28.2M 1.34%
269,505
+43,868
+19% +$4.51M
JNJ icon
12
Johnson & Johnson
JNJ
$615B
$25.8M 1.22%
250,696
-11,643
-4% -$1.17M
GOOG icon
13
Alphabet (Google) Class C
GOOG
$4.17T
$24.7M 1.17%
650,260
-399,140
-38% -$14.3M
VRTX icon
14
Vertex Pharmaceuticals
VRTX
$120B
$23.8M 1.13%
189,113
+1,006
+0.5% +$121K
GOOGL icon
15
Alphabet (Google) Class A
GOOGL
$4.17T
$22.8M 1.08%
+586,420
New +$21.7M
ILMN icon
16
Illumina
ILMN
$28.9B
$21.7M 1.03%
116,306
+3,775
+3% +$609K
INTC icon
17
Intel
INTC
$516B
$20.4M 0.97%
592,678
+152,218
+35% +$5.15M
XOM icon
18
ExxonMobil
XOM
$640B
$18.7M 0.89%
240,516
+7,326
+3% +$586K
PFE icon
19
Pfizer
PFE
$141B
$17.8M 0.85%
582,397
-13,250
-2% -$417K
BXLT
20
DELISTED
BAXALTA INC COM STK (DE)
BXLT
$15.2M 0.72%
388,909
-944
-0.2% -$32.9K
INCY icon
21
Incyte
INCY
$23.1B
$14M 0.66%
128,829
+12,533
+11% +$1.4M
MRK icon
22
Merck
MRK
$315B
$13M 0.62%
258,869
-20,581
-7% -$1.04M
CMCSA icon
23
Comcast
CMCSA
$84B
$12.9M 0.61%
457,720
+101,444
+28% +$3.06M
BMRN icon
24
BioMarin Pharmaceuticals
BMRN
$11.3B
$12.8M 0.61%
121,911
+37
+0% +$3.86K
AGN
25
DELISTED
Allergan plc
AGN
$11.1M 0.53%
35,555
-1,516
-4% -$451K

Similar funds

Profund Advisors's Q4 2015 Portfolio in Review

As of Q4 2015, Profund Advisors held 1,348 positions worth $2.11B, up 20% from $1.75B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Profund Advisors deployed $219M of net new capital in Q4 2015, opening 141 new positions and adding to 949 existing holdings. Its largest new stake was Alphabet (Google) Class A: 586,420 shares worth $22.8M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 42% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $14.3M trimmed.

  • Profund Advisors's largest Q4 2015 buy was Alphabet (Google) Class A: 586,420 shares worth $22.8M.
  • Profund Advisors added most to Apple in Q4 2015, an estimated $6.71M increase.
  • Profund Advisors's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $14.3M.
  • Profund Advisors fully exited COMCAST CORP SPL A (NEW) in Q4 2015, selling an estimated $1.77M.
  • Profund Advisors's ten largest holdings make up 28% of its $2.11B portfolio in Q4 2015.
  • Profund Advisors opened 141 new positions and closed 51 in Q4 2015.
  • Profund Advisors's portfolio value rose 20% quarter-over-quarter to $2.11B.

Based on Profund Advisors's 13F filing for Q4 2015, filed 5 Feb 2016.